Download Content

Nanofitin-Antibody fusion as a novel multispecific platform: providing extra specificities while maintaining developability

Please enter your details into the form below to access the Webinar on Nanofitin-Antibody Fusion as a Novel Multispecific Platform hosted with Mathieu Cinier, Scientific Director, Affilogic

Contact Form

Submit your details to register your interest & to be kept up to date about relevant events. You may opt-out at any time. Please check our Privacy Policy to see how Oxford Global protects and manages your data.